Journal
SEMINARS IN CANCER BIOLOGY
Volume 11, Issue 5, Pages 339-352Publisher
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1006/scbi.2001.0389
Keywords
antiestrogens; breast cancer; co-regulatory factors; estrogen receptor
Categories
Ask authors/readers for more resources
Breast cancer, the most common malignancy in women, was already known to be associated with the steroid hormone estrogen more than a century ago. The discovery of the estrogen receptor (ER) provided us not only with a powerful predictive and prognostic marker, but also an efficient target for the treatment of hormone-dependent breast cancer with antiestrogens. In this paper we will sketch the important role of ER in the development, progression, and treatment of the disease, which is complicated by the receptor's interaction with coregulatory proteins, its cross-talk with other signal transduction pathways, and its involvement in the development of antiestrogen resistance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available